These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15663275)

  • 1. Surgical interventions during STI 571 treatment of metastatic GIST: experience in six patients.
    Nevelsteen I; De Wever I; Stas M; Devroe H; Dumez H; Van Oosterom A
    Acta Chir Belg; 2004; 104(6):683-9. PubMed ID: 15663275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal stromal tumors: diagnosis and treatment.
    Acín-Gándara D; Pereira-Pérez F; Castaño-Pascual A; Durán-Poveda M; Antequera-Pérez A; Miliani-Molina C
    Cir Cir; 2012; 80(1):44-51. PubMed ID: 22472152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a role of surgery in patients with recurrent or metastatic gastrointestinal stromal tumours responding to imatinib: a prospective randomised trial in China.
    Du CY; Zhou Y; Song C; Wang YP; Jie ZG; He YL; Liang XB; Cao H; Yan ZS; Shi YQ
    Eur J Cancer; 2014 Jul; 50(10):1772-1778. PubMed ID: 24768330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined surgical and molecular therapy: the gastrointestinal stromal tumor model.
    Gold JS; Dematteo RP
    Ann Surg; 2006 Aug; 244(2):176-84. PubMed ID: 16858179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
    Croom KF; Perry CM
    Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imatinib for the treatment of patients with unresectable or metastatic malignant KIT-positive gastrointestinal stromal tumours: an open-label Belgian trial.
    Prenen H; Dumez H; Stefan C; Hoeben A; Wouters C; Van Lierde MA; Sciot R; van Oosterom AT; Peeters M; Polus M; Duck L; Gil T; Schöffski P
    Acta Gastroenterol Belg; 2006; 69(4):367-71. PubMed ID: 17343077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for primary gastrointestinal stromal tumours: are they the same in the multidisciplinary treatment era?
    Cananzi FC; Lorenzi B; Belgaumkar A; Benson C; Judson I; Mudan S
    Langenbecks Arch Surg; 2014 Mar; 399(3):323-32. PubMed ID: 24413830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical treatment of gastrointestinal stromal tumors in the imatinib (STI-571) era.
    Wu PC; Langerman A; Ryan CW; Hart J; Swiger S; Posner MC
    Surgery; 2003 Oct; 134(4):656-65; discussion 665-6. PubMed ID: 14605627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy and target-therapy of gastrointestinal tumors call for development of pathology].
    Shen L
    Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):438-9. PubMed ID: 17845753
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of operative therapy in treatment of metastatic gastrointestinal stromal tumors.
    Zaydfudim V; Okuno SH; Que FG; Nagorney DM; Donohue JH
    J Surg Res; 2012 Oct; 177(2):248-54. PubMed ID: 22831567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiologic assessment of earliest, best, and plateau response of gastrointestinal stromal tumors to neoadjuvant imatinib prior to successful surgical resection.
    Tirumani SH; Shinagare AB; Jagannathan JP; Krajewski KM; Ramaiya NH; Raut CP
    Eur J Surg Oncol; 2014 Apr; 40(4):420-8. PubMed ID: 24238762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular and histologic characteristics of secondary imatinib-resistant gastrointestinal stromal tumors].
    Zheng S; Jia J; Pan YL; Tao DY; Lu HS
    Zhonghua Bing Li Xue Za Zhi; 2013 Jan; 42(1):42-3. PubMed ID: 23611272
    [No Abstract]   [Full Text] [Related]  

  • 13. Advanced or metastatic gastrointestinal stromal tumors: systemic treatment options.
    Caram MV; Schuetze SM
    J Surg Oncol; 2011 Dec; 104(8):888-95. PubMed ID: 22069173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal stromal tumours: etiology, pathology and clinical management.
    Blackstein ME; Dubé P; Fletcher JA; Keller OR; Knowling M; Létourneau R; Morris D; Riddell R; Rorke S; Swallow CJ;
    Can J Gastroenterol; 2004 Sep; 18 Suppl B():3B-8B. PubMed ID: 15457300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New prospective on adjuvant treatment for gastrointestinal stromal tumors].
    Pan ZZ; Wu XJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):212-5. PubMed ID: 23536337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Curative resection for bulky gastrointestinal stromal tumor with conversion therapy by imatinib].
    Nishimura T; Sakata K; Maeda Y; Nagashima Y; Okada T; Nakamura M; Setoguchi M
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2202-4. PubMed ID: 22202330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presentation and management of gastrointestinal stromal tumours.
    Mongan AM; Malik V; Rowley S; Claxton Z; Muldoon C; O'Toole D; Ravi N; Reynolds JV
    Ir Med J; 2013 Jun; 106(6):176-9. PubMed ID: 23909154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [GIST: our experience].
    Rossi MT; Fasano G; Morlino A; Scutari F
    G Chir; 2009; 30(1-2):41-5. PubMed ID: 19272232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updates on the management of gastrointestinal stromal tumors.
    Bamboat ZM; Dematteo RP
    Surg Oncol Clin N Am; 2012 Apr; 21(2):301-16. PubMed ID: 22365521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib.
    Bauer S; Hartmann JT; de Wit M; Lang H; Grabellus F; Antoch G; Niebel W; Erhard J; Ebeling P; Zeth M; Taeger G; Seeber S; Flasshove M; Schütte J
    Int J Cancer; 2005 Nov; 117(2):316-25. PubMed ID: 15900603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.